Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients

Dyslipidemia is a widespread risk factor in solid organ transplant patients, due to many reasons, such as the use of immunosuppressive drugs, with a consequent increase in cardiovascular diseases in this population. PCSK9 is an enzyme mainly known for its role in altering LDL levels, consequently in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuomo, Gianluigi, Cioffi, Giuseppe, Di Lorenzo, Anna, Iannone, Francesca Paola, Cudemo, Giuseppe, Iannicelli, Anna Maria, Pacileo, Mario, D’Andrea, Antonello, Vigorito, Carlo, Iannuzzo, Gabriella, Giallauria, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180971/
https://www.ncbi.nlm.nih.gov/pubmed/35683632
http://dx.doi.org/10.3390/jcm11113247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180971/
https://www.ncbi.nlm.nih.gov/pubmed/35683632
http://dx.doi.org/10.3390/jcm11113247

Ejemplares similares